|
1
|
American Diabetes Association. 2.
Classification and diagnosis of diabetes: Standards of medical care
in diabetes-2019. Diabetes Care. 42 (Suppl 1):S13–S28.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Skajaa GO, Fuglsang J, Knorr S, Møller N,
Ovesen P and Kampmann U: Changes in insulin sensitivity and insulin
secretion during pregnancy and post partum in women with
gestational diabetes. BMJ Open Diabetes Res Care.
8(e001728)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Prentki M and Nolan CJ: Islet beta cell
failure in type 2 diabetes. J Clin Invest. 116:1802–1812.
2006.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Catalano PM: Trying to understand
gestational diabetes. Diabet Med. 31:273–281. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Khambule L and George JA: The role of
inflammation in the development of GDM and the use of markers of
inflammation in GDM screening. Adv Exp Med Biol. 1134:217–242.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bootcov MR, Bauskin AR, Valenzuela SM,
Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor
K, et al: MIC-1, a novel macrophage inhibitory cytokine, is a
divergent member of the TGF-beta superfamily. Proc Natl Acad Sci
USA. 94:11514–11519. 1997.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ding Q, Mracek T, Gonzalez-Muniesa P, Kos
K, Wilding J, Trayhurn P and Bing C: Identification of macrophage
inhibitory cytokine-1 in adipose tissue and its secretion as an
adipokine by human adipocytes. Endocrinology. 150:1688–1696.
2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Brown DA, Breit SN, Buring J, Fairlie WD,
Bauskin AR, Liu T and Ridker PM: Concentration in plasma of
macrophage inhibitory cytokine-1 and risk of cardiovascular events
in women: A nested case-control study. Lancet. 359:2159–2163.
2002.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Marjono AB, Brown DA, Horton KE, Wallace
EM, Breit SN and Manuelpillai U: Macrophage inhibitory cytokine-1
in gestational tissues and maternal serum in normal and
pre-eclamptic pregnancy. Placenta. 24:100–106. 2003.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Xu J, Kimball TR, Lorenz JN, Brown DA,
Bauskin AR, Klevitsky R, Hewett TE, Breit SN and Molkentin JD:
GDF15/MIC-1 functions as a protective and antihypertrophic factor
released from the myocardium in association with SMAD protein
activation. Circ Res. 98:342–350. 2006.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ho JE, Mahajan A, Chen MH, Larson MG,
McCabe EL, Ghorbani A, Cheng S, Johnson AD, Lindgren CM, Kempf T,
et al: Clinical and genetic correlates of growth differentiation
factor 15 in the community. Clin Chem. 58:1582–1591.
2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mehta RS, Song M, Bezawada N, Wu K,
Garcia-Albeniz X, Morikawa T, Fuchs CS, Ogino S, Giovannucci EL and
Chan AT: A prospective study of macrophage inhibitory cytokine-1
(MIC-1/GDF15) and risk of colorectal cancer. J Natl Cancer Inst.
106(dju016)2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Xiao QA, He Q, Zeng J and Xia X: GDF-15, a
future therapeutic target of glucolipid metabolic disorders and
cardiovascular disease. Biomed Pharmacother.
146(112582)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yalcin MM, Altinova AE, Akturk M, Gulbahar
O, Arslan E, Ors Sendogan D, Yetkin I and Toruner FB: GDF-15 and
hepcidin levels in nonanemic patients with impaired glucose
tolerance. J Diabetes Res. 2016(1240843)2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Schernthaner-Reiter MH, Kasses D,
Tugendsam C, Riedl M, Peric S, Prager G, Krebs M,
Promintzer-Schifferl M, Clodi M, Luger A and Vila G: Growth
differentiation factor 15 increases following oral glucose
ingestion: Effect of meal composition and obesity. Eur J
Endocrinol. 175:623–631. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Simm A, Nass N, Bartling B, Hofmann B,
Silber RE and Navarrete Santos A: Potential biomarkers of ageing.
Biol Chem. 389:257–265. 2008.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Vila G, Riedl M, Anderwald C, Resl M,
Handisurya A, Clodi M, Prager G, Ludvik B, Krebs M and Luger A: The
relationship between insulin resistance and the cardiovascular
biomarker growth differentiation factor-15 in obese patients. Clin
Chem. 57:309–316. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hong JH, Chung HK, Park HY, Joung KH, Lee
JH, Jung JG, Kim KS, Kim HJ, Ku BJ and Shong M: GDF15 is a novel
biomarker for impaired fasting glucose. Diabetes Metab J.
38:472–479. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li E, Chen P, Lu J, Dai J, Yi J, Zhang S,
Jin H, Guo M, Wang H and Yu X: Serum growth differentiation factor
15 is closely associated with metabolic abnormalities in Chinese
pregnant women. J Diabetes Investig. 12:1501–1507. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Banerjee S, Bhattacharjee R, Sur A,
Adhikary P and Chowdhury S: A study of serum growth differentiation
factor 15 in Indian women with and without gestational diabetes
mellitus in the third trimester of pregnancy and its association
with pro-inflammatory markers and glucose metabolism. Diabetol Int.
12:254–259. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Immanuel J and Simmons D: Screening and
treatment for early-onset gestational diabetes mellitus: A
systematic review and meta-analysis. Curr Diab Rep.
17(115)2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
No authors listed. Diagnostic criteria and
classification of hyperglycaemia first detected in pregnancy: A
World Health Organization guideline. Diabetes Res Clin Pract.
103:341–363. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chi C, Loy SL, Chan SY, Choong C, Cai S,
Soh SE, Tan KH, Yap F, Gluckman PD, Godfrey KM, et al: Impact of
adopting the 2013 World Health Organization criteria for diagnosis
of gestational diabetes in a multi-ethnic Asian cohort: A
prospective study. BMC Pregnancy Childbirth. 18(69)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
de Jong PE, Gansevoort RT and Bakker SJL:
Macroalbuminuria and microalbuminuria: Do both predict renal and
cardiovascular events with similar strength? J Nephrol. 20:375–380.
2007.PubMed/NCBI
|
|
25
|
American Diabetes Association. 2.
Classification and diagnosis of diabetes: Standards of medical care
in diabetes-2018. Diabetes Care. 41 (Suppl 1):S13–S27.
2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Görkem Ü, Küçükler FK, Toğrul C and Güngör
T: Are adipokines associated with gestational diabetes mellitus? J
Turk Ger Gynecol Assoc. 17:186–190. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Reece EA, Leguizamón G and Wiznitzer A:
Gestational diabetes: The need for a common ground. Lancet.
373:1789–1797. 2009.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bellamy L, Casas JP, Hingorani AD and
Williams D: Type 2 diabetes mellitus after gestational diabetes: A
systematic review and meta-analysis. Lancet. 373:1773–1779.
2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Carr DB, Utzschneider KM, Hull RL, Tong J,
Wallace TM, Kodama K, Shofer JB, Heckbert SR, Boyko EJ, Fujimoto WY
and Kahn SE: Gestational diabetes mellitus increases the risk of
cardiovascular disease in women with a family history of type 2
diabetes. Diabetes Care. 29:2078–2083. 2006.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gao C, Sun X, Lu L, Liu F and Yuan J:
Prevalence of gestational diabetes mellitus in mainland China: A
systematic review and meta-analysis. J Diabetes Investig.
10:154–162. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Burlina S, Dalfrà MG, Chilelli NC and
Lapolla A: Gestational diabetes mellitus and future cardiovascular
risk: An update. Int J Endocrinol. 2016(2070926)2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yarsilikal Guleroglu F, Selvi E, Turan
Bakirci I, Bafalı O, Argun Atalmis H, Yasti Dayan M, Balkan Ozmen
A, Yurtcu N, Seker Atas B, Ozdemir Anayurt E and Cetin A: Clinical
value of serum BMP-4, BMP-2, GDF-15, MMP-9, GP39 levels in pregnant
women with obesity and the related comorbidities diabetes mellitus
and gestational hypertension. Z Geburtshilfe Neonatol. 227:42–50.
2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Berezin AE: Diabetes mellitus related
biomarker: The predictive role of growth-differentiation factor-15.
Diabetes Metab Syndr. 10 (1 Suppl 1):S154–S157. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Sugulle M, Dechend R, Herse F,
Weedon-Fekjaer MS, Johnsen GM, Brosnihan KB, Anton L, Luft FC,
Wollert KC, Kempf T and Staff AC: Circulating and placental
growth-differentiation factor 15 in preeclampsia and in pregnancy
complicated by diabetes mellitus. Hypertension. 54:106–112.
2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yakut K, Öcal DF, Öztürk FH, Öztürk M,
Oğuz Y, Sınacı S and Çağlar T: Is GDF-15 level associated with
gestational diabetes mellitus and adverse perinatal outcomes?
Taiwan J Obstet Gynecol. 60:221–224. 2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lu YC, Liu SL, Zhang YS, Liang F, Zhu XY,
Xiao Y, Wang J, Ding C, Banerjee S, Yin JY and Ma QP: Association
between growth differentiation factor 15 levels and gestational
diabetes mellitus: A combined analysis. Front Endocrinol
(Lausanne). 14(1084896)2023.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Andersson-Hall U, Joelsson L, Svedin P,
Mallard C and Holmäng A: Growth-differentiation-factor 15 levels in
obese and healthy pregnancies: Relation to insulin resistance and
insulin secretory function. Clin Endocrinol (Oxf). 95:92–100.
2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Andersson-Hall U, Svedin P, Mallard C,
Blennow K, Zetterberg H and Holmäng A: Growth differentiation
factor 15 increases in both cerebrospinal fluid and serum during
pregnancy. PLoS One. 16(e0248980)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Berkowitz GS, Roman SH, Lapinski RH and
Alvarez M: Maternal characteristics, neonatal outcome, and the time
of diagnosis of gestational diabetes. Am J Obstet Gynecol.
167:976–982. 1992.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Shin MY, Kim JM, Kang YE, Kim MK, Joung
KH, Lee JH, Kim KS, Kim HJ, Ku BJ and Shong M: Association between
growth differentiation factor 15 (GDF15) and cardiovascular risk in
patients with newly diagnosed type 2 diabetes mellitus. J Korean
Med Sci. 31:1413–1418. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Hellemons ME, Mazagova M, Gansevoort RT,
Henning RH, de Zeeuw D, Bakker SJ, Lambers-Heerspink HJ and Deelman
LE: Growth-differentiation factor 15 predicts worsening of
albuminuria in patients with type 2 diabetes. Diabetes Care.
35:2340–2346. 2012.PubMed/NCBI View Article : Google Scholar
|
